Download PDF
CC BY-NC-ND 4.0 · Journal of Gastrointestinal and Abdominal Radiology 2022; 05(01): 070-074
DOI: 10.1055/s-0041-1740478
Case Report

Post-Covid Renal Mucormycosis: A Case Report

B. Madhumitha
1   Department of Imaging and Interventional Radiology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
,
Ganesh Rajagopal
1   Department of Imaging and Interventional Radiology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
,
N. Karunakaran
1   Department of Imaging and Interventional Radiology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
,
T. Mukuntharajan 
1   Department of Imaging and Interventional Radiology, Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

The Pandora's box has been opened in the twenty-first century unleashing “the Coronavirus.” There has been an increase in the incidence of mucormycosis during this coronavirus disease 2019 (COVID-19) pandemic with many case reports of rhino-orbito-cerebral and pulmonary mucormycosis. Diabetes mellitus, COVID, and Mucor fungus together are a dangerous trio associated with high mortality. We report a rare case of renal mucormycosis following COVID pneumonia in a 64-year-old patient with uncontrolled diabetes; with the imaging findings of left emphysematous pyelonephritis and cystitis, nonfunctioning left kidney, and left main renal artery and vein thrombosis. This is the first such case reported to our knowledge. A high degree of clinical suspicion with prompt recognition of imaging findings is essential to improve the chances of survival in such patients.

Keywords

COVID-19 - diabetes - renal mucormycosis


Publication History

Article published online:
24 January 2022

© 2021. Indian Society of Gastrointestinal and Abdominal Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 WHO Coronavirus disease (COVID-19) Dashboard with vaccination data. Accessed July 30, 2021 at: https://www.covid19.who.int/
    Google Scholar
  • 2 Salehi M, Ahmadikia K, Badali H, Khodavaisy S, Badali H, Khodavaisy S. Opportunistic fungal infections in the epidemic area of COVID-19; a clinical and diagnostic perspective from Iran. Mycopathologia 2020; 185 (04) 607-611
    CrossrefPubMedGoogle Scholar
  • 3 Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15 (04) 102146
    CrossrefPubMedGoogle Scholar
  • 4 Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18 (03) 556-569
    CrossrefPubMedGoogle Scholar
  • 5 Choudhary GR, Aggarwal A, Jain V, Jena R. COVID-19 and fatal renal mucormycosis: contributory or coincidental?. Indian J Urol 2021; 37 (03) 270-273
    CrossrefPubMedGoogle Scholar
  • 6 Singh T, Chaudhari R, Gupta A. Renal artery thrombosis and mucormycosis in a COVID-19 patient. Indian J Urol 2021; 37 (03) 267-269
    CrossrefPubMedGoogle Scholar
  • 7 Roden MM, Zaoutis TE, Buchanan WL. et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41 (05) 634-653
    CrossrefPubMedGoogle Scholar
  • 8 Agrawal R, Yeldandi A, Savas H, Parekh ND, Lombardi PJ, Hart EM. Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic correlation. Radiographics 2020; 40 (03) 656-666
    CrossrefPubMedGoogle Scholar
  • 9 Mishra Y, Prashar M, Sharma D, Akash. Kumar VP, Tilak TVSVGK. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr 2021; 15 (04) 102196
    CrossrefPubMedGoogle Scholar
  • 10 Garg D, Muthu V, Sehgal IS. et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021; 186 (02) 289-298
    CrossrefPubMedGoogle Scholar
  • 11 Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA. COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 2020; 80 (05) 554-562
    CrossrefPubMedGoogle Scholar
  • 12 Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis-the bitter and the sweet. PLoS Pathog 2017; 13 (08) e1006408
    CrossrefPubMedGoogle Scholar
  • 13 Seoane PI, Taylor-Smith LM, Stirling D. et al. Viral infection triggers interferon-induced expulsion of live Cryptococcus neoformans by macrophages. PLoS Pathog 2020; 16 (02) e1008240
    CrossrefPubMedGoogle Scholar
  • 14 Gupta KL, Joshi K, Sud K. et al. Renal zygomycosis: an under-diagnosed cause of acute renal failure. Nephrol Dial Transplant 1999; 14 (11) 2720-2725
    CrossrefPubMedGoogle Scholar
  • 15 Levy E, Bia MJ. Isolated renal mucormycosis: case report and review. J Am Soc Nephrol 1995; 5 (12) 2014-2019
    CrossrefPubMedGoogle Scholar
  • 16 Keogh CF, Brown JA, Phillips P, Cooperberg PL. Renal mucormycosis in an AIDS patient: imaging features and pathologic correlation. AJR Am J Roentgenol 2003; 180 (05) 1278-1280
    CrossrefPubMedGoogle Scholar
  • 17 Ranjan P, Naval R, Singh R, Gupta RK, Kapoor R, Sharma RK. Emerging role of radiological criteria for antemortem diagnosis of renal zygomycosis: an uncommon cause of acute renal failure. NDT Plus 2011; 4 (05) 335-338
    PubMedGoogle Scholar
  • 18 Orlowski HLP, McWilliams S, Mellnick VM. et al. Imaging spectrum of invasive fungal and fungal-like infections. Radiographics 2017; 37 (04) 1119-1134
    CrossrefPubMedGoogle Scholar